The impact of firm-specific capabilities on the amount of capital raised in an initial public offering : evidence from the biotechnology industry
Year of publication: |
1997
|
---|---|
Authors: | Deeds, David L. |
Other Persons: | Decarolis, Dona (contributor) ; Coombs, Joseph E. (contributor) |
Published in: |
Journal of business venturing. - New York, NY : Elsevier Science Publ., ISSN 0883-9026, ZDB-ID 633944-X. - Vol. 12.1997, 1, p. 31-46
|
Subject: | Emissionsgeschäft | Underwriting business | Unternehmensfinanzierung | Corporate finance | Biotechnologie-Industrie | Biotechnology industry | USA | United States | 1992 |
-
Initial public offering and financing of biotechnology start-ups : evidence from Japan
Honjō, Yūji, (2015)
-
Initial public offering and financing of biotechnology start-ups : evidence from Japan
Honjō, Yūji, (2018)
-
Zugang deutscher Unternehmen zum US-Kapitalmarkt
Rosen, Rüdiger von, (1996)
- More ...
-
Deeds, David L., (2000)
-
Coombs, Joseph E., (2009)
-
Coombs, Joseph E., (2006)
- More ...